Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02154568
27:30:treatment
Any condition for which a MRI procedure is contraindicated
3
[ "Any", "condition", "for", "which", "a", "MRI", "procedure", "is", "contraindicated" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02332668
12:34:treatment
has failed prior standard therapy
3
[ "has", "failed", "prior", "standard", "therapy" ]
[ 0, 0, 1, 1, 1 ]
NCT00293475
12:59:cancer
high-grade primary central nervous system lymphoma (PCNSL) as documented by brain biopsy
3
[ "high-grade", "primary", "central", "nervous", "system", "lymphoma", "(", "PCNSL", ")", "as", "documented", "by", "brain", "biopsy" ]
[ 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT01653093
,,,108:111:treatment
Patients must have an estimated glomerular filtration rate of >= 30 mL/min/1.73m^2 within six weeks of the MRI
3
[ "Patients", "must", "have", "an", "estimated", "glomerular", "filtration", "rate", "of", ">", "=", "30", "mL/min/1.73m^2", "within", "six", "weeks", "of", "the", "MRI" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02100891
1:11:cancer,23:45:cancer,82:108:treatment
CNS tumors: High risk malignant brain tumors that are recurrent or refractory to standard frontline therapy are eligible
3
[ "CNS", "tumors", ":", "High", "risk", "malignant", "brain", "tumors", "that", "are", "recurrent", "or", "refractory", "to", "standard", "frontline", "therapy", "are", "eligible" ]
[ 3, 3, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0 ]
NCT02913495
1:16:chronic_disease
Placenta previa
3
[ "Placenta", "previa" ]
[ 2, 2 ]
NCT02799095
,65:89:treatment,,
A female not of childbearing potential is one who has undergone bilateral oophorectomies or who is postmenopausal, defined as >45 years of age and without a menstrual period for 12 consecutive months
3
[ "A", "female", "not", "of", "childbearing", "potential", "is", "one", "who", "has", "undergone", "bilateral", "oophorectomies", "or", "who", "is", "postmenopausal", ",", "defined", "as", ">", "45", "years", "of", "age", "and", "without", "a", "menstrual", "period", "for", "12", "consecutive", "months" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01810588
1:25:cancer
Myelodysplastic syndrome
3
[ "Myelodysplastic", "syndrome" ]
[ 3, 3 ]
NCT01494324
22:30:treatment
Patients who are not surgical candidates
3
[ "Patients", "who", "are", "not", "surgical", "candidates" ]
[ 0, 0, 0, 0, 1, 0 ]
NCT03100539
25:47:chronic_disease
Complex neck pain (e.g. cervical radiculopathy or recent whiplash injury)
3
[ "Complex", "neck", "pain", "(", "e.g", ".", "cervical", "radiculopathy", "or", "recent", "whiplash", "injury", ")" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT02390752
1:5:treatment,,45:65:treatment,93:115:chronic_disease
HSCT: greater than or equal to 56 days from stem cell transplant with no evidence of active graft vs. host disease
3
[ "HSCT", ":", "greater", "than", "or", "equal", "to", "56", "days", "from", "stem", "cell", "transplant", "with", "no", "evidence", "of", "active", "graft", "vs.", "host", "disease" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 2, 2, 2, 2 ]
NCT02068612
8:21:treatment
Are on antipsychotic medications
3
[ "Are", "on", "antipsychotic", "medications" ]
[ 0, 0, 1, 0 ]
NCT02690116
7:33:chronic_disease
Major severe clinical depression (fatigue-related factor)
3
[ "Major", "severe", "clinical", "depression", "(", "fatigue-related", "factor", ")" ]
[ 0, 2, 2, 2, 0, 0, 0, 0 ]
NCT02506192
9:17:chronic_disease
Treated Diabetes
3
[ "Treated", "Diabetes" ]
[ 0, 2 ]
NCT02442102
39:52:chronic_disease,56:81:chronic_disease,89:95:chronic_disease,97:111:chronic_disease,113:124:chronic_disease
Presence of a central nervous system, neuromuscular or connective tissue disease (e.g., stroke, Guillain-Barre, scleroderma)
3
[ "Presence", "of", "a", "central", "nervous", "system", ",", "neuromuscular", "or", "connective", "tissue", "disease", "(", "e.g.", ",", "stroke", ",", "Guillain-Barre", ",", "scleroderma", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2, 0, 0, 0, 2, 0, 2, 0, 2, 0 ]
NCT02422641
7:25:treatment,,,
Whole brain radiotherapy within the last 6 months or partial brain radiotherapy exceeding greater than 40% of total brain volume in the last 6 months
3
[ "Whole", "brain", "radiotherapy", "within", "the", "last", "6", "months", "or", "partial", "brain", "radiotherapy", "exceeding", "greater", "than", "40", "%", "of", "total", "brain", "volume", "in", "the", "last", "6", "months" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03113136
12:37:chronic_disease,
history of cardiac event or distress within the past 3 months
3
[ "history", "of", "cardiac", "event", "or", "distress", "within", "the", "past", "3", "months" ]
[ 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT00967577
8:22:treatment,26:47:treatment,,66:75:treatment
Use of red blood cell or platelet transfusions within 4 weeks of treatment
3
[ "Use", "of", "red", "blood", "cell", "or", "platelet", "transfusions", "within", "4", "weeks", "of", "treatment" ]
[ 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 0, 0, 1 ]
NCT01130077
8:26:treatment,
Use of immunosuppressives within four weeks prior to study entry
3
[ "Use", "of", "immunosuppressives", "within", "four", "weeks", "prior", "to", "study", "entry" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT03181867
26:56:cancer
Histologically confirmed adenocarcinoma of the prostate
3
[ "Histologically", "confirmed", "adenocarcinoma", "of", "the", "prostate" ]
[ 0, 0, 3, 3, 3, 3 ]
NCT02578732
24:38:treatment,32:37:treatment,47:61:treatment
Patients with unstable biliary stents or with plastic stents. Information on type of stent is required at registration
3
[ "Patients", "with", "unstable", "biliary", "stents", "or", "with", "plastic", "stents", ".", "Information", "on", "type", "of", "stent", "is", "required", "at", "registration" ]
[ 0, 0, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02219555
1:23:chronic_disease
cervical radiculopathy
3
[ "cervical", "radiculopathy" ]
[ 2, 2 ]
NCT02535832
1:8:treatment
Insulin resistant according to the Matsuda index
3
[ "Insulin", "resistant", "according", "to", "the", "Matsuda", "index" ]
[ 1, 0, 0, 0, 0, 0, 0 ]
NCT02525861
9:25:chronic_disease,31:54:chronic_disease,56:79:chronic_disease,81:104:chronic_disease,109:155:chronic_disease
Ongoing active infection with hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV) Type 1 or 2 infection at the time of screening
3
[ "Ongoing", "active", "infection", "with", "hepatitis", "A", "virus", "(", "HAV", ")", ",", "hepatitis", "B", "virus", "(", "HBV", ")", ",", "hepatitis", "C", "virus", "(", "HCV", ")", ",", "or", "human", "immunodeficiency", "virus", "(", "HIV", ")", "Type", "1", "or", "2", "infection", "at", "the", "time", "of", "screening" ]
[ 0, 2, 2, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02365090
,,33:39:chronic_disease,43:59:chronic_disease,,,117:131:chronic_disease
Prematurity ≥8 weeks Coexisting ocular or systemic disease Developmental delay Poor ocular alignment (strabismus >5 prism diopters)
3
[ "Prematurity", "≥8", "weeks", "Coexisting", "ocular", "or", "systemic", "disease", "Developmental", "delay", "Poor", "ocular", "alignment", "(", "strabismus", ">", "5", "prism", "diopters", ")" ]
[ 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0 ]
NCT01964859
7:24:chronic_disease
Known bleeding disorder
3
[ "Known", "bleeding", "disorder" ]
[ 0, 2, 2 ]
NCT02520713
36:54:treatment
Patients who have declined further anticancer therapy
3
[ "Patients", "who", "have", "declined", "further", "anticancer", "therapy" ]
[ 0, 0, 0, 0, 0, 1, 1 ]
NCT02843646
1:8:chronic_disease
Seizure history interfering with use of functional electrical stimulation as verified by their MD
3
[ "Seizure", "history", "interfering", "with", "use", "of", "functional", "electrical", "stimulation", "as", "verified", "by", "their", "MD" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01918644
9:42:cancer
treated non-melanoma/melanoma skin cancer
3
[ "treated", "non-melanoma/melanoma", "skin", "cancer" ]
[ 0, 3, 3, 3 ]
NCT02110069
123:131:chronic_disease,146:158:chronic_disease,178:197:chronic_disease,199:212:chronic_disease,216:229:chronic_disease,238:263:chronic_disease
Concurrent severe and/or uncontrolled medical disease that could compromise participation in the study (e.g. uncontrolled diabetes, uncontrolled hypertension, severe infection, severe malnutrition, chronic liver or renal disease, active upper GI tract ulceration)
3
[ "Concurrent", "severe", "and/or", "uncontrolled", "medical", "disease", "that", "could", "compromise", "participation", "in", "the", "study", "(", "e.g", ".", "uncontrolled", "diabetes", ",", "uncontrolled", "hypertension", ",", "severe", "infection", ",", "severe", "malnutrition", ",", "chronic", "liver", "or", "renal", "disease", ",", "active", "upper", "GI", "tract", "ulceration", ")" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 2, 2, 2, 2, 0 ]
NCT00862433
1:18:chronic_disease,51:64:chronic_disease,66:83:chronic_disease,85:107:chronic_disease,109:122:chronic_disease,124:130:chronic_disease,132:159:chronic_disease
Organ malfunction, including (but not limited to) liver disease, pulmonary disease, ischemic heart disease, heart failure, stroke, peripheral vascular disease
3
[ "Organ", "malfunction", ",", "including", "(", "but", "not", "limited", "to", ")", "liver", "disease", ",", "pulmonary", "disease", ",", "ischemic", "heart", "disease", ",", "heart", "failure", ",", "stroke", ",", "peripheral", "vascular", "disease" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 2, 0, 2, 2, 2 ]
NCT02440581
62:77:chronic_disease,79:99:chronic_disease,101:111:chronic_disease
Clinical condition that may limit study participation (e.g., unstable angina, respiratory distress, infections)
3
[ "Clinical", "condition", "that", "may", "limit", "study", "participation", "(", "e.g.", ",", "unstable", "angina", ",", "respiratory", "distress", ",", "infections", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 2, 0 ]
NCT02174016
12:27:chronic_disease
History of nephrolithiasis
3
[ "History", "of", "nephrolithiasis" ]
[ 0, 0, 2 ]
NCT03040778
17:34:treatment
Patients taking CYP1A2 inhibitors
3
[ "Patients", "taking", "CYP1A2", "inhibitors" ]
[ 0, 0, 1, 1 ]
NCT01893554
20:57:chronic_disease,98:101:chronic_disease,118:143:treatment,154:178:treatment,182:193:treatment,194:216:treatment
Known or suspected impairment of immunological functions, including maternal history of positive HIV test, receiving immunosuppressive therapy including systemic corticosteroids or bone marrow/solid organ transplant recipients
3
[ "Known", "or", "suspected", "impairment", "of", "immunological", "functions", ",", "including", "maternal", "history", "of", "positive", "HIV", "test", ",", "receiving", "immunosuppressive", "therapy", "including", "systemic", "corticosteroids", "or", "bone", "marrow/solid", "organ", "transplant", "recipients" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 1, 1, 0, 1, 1, 0, 1, 1, 1, 1, 0 ]
NCT02352467
18:24:chronic_disease
Stage I pressure ulcers
3
[ "Stage", "I", "pressure", "ulcers" ]
[ 0, 0, 0, 2 ]
NCT02532595
1:16:chronic_disease
Fear of needles or unwilling to have needling performed due to fear or personal beliefs
3
[ "Fear", "of", "needles", "or", "unwilling", "to", "have", "needling", "performed", "due", "to", "fear", "or", "personal", "beliefs" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01054196
102:114:allergy_name,126:137:allergy_name,142:151:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to lenalidomide (including thalidomide) or melphalan
3
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "lenalidomide", "(", "including", "thalidomide", ")", "or", "melphalan" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 4, 0, 0, 4 ]
NCT02502006
1:21:cancer,25:45:cancer,58:66:treatment,71:102:cancer
cutaneous basal cell or squamous cell cancer resolved by excision, or carcinoma in situ of the cervix adequately treated
3
[ "cutaneous", "basal", "cell", "or", "squamous", "cell", "cancer", "resolved", "by", "excision", ",", "or", "carcinoma", "in", "situ", "of", "the", "cervix", "adequately", "treated" ]
[ 3, 3, 3, 0, 3, 3, 3, 0, 0, 1, 0, 0, 3, 3, 3, 3, 3, 3, 0, 0 ]
NCT02562235
1:20:chronic_disease,,
Renal insufficiency (estimated glomerular filtration rate <30 mL/min/1.73m2 e.g. calculated based on Schwartz formula, for detailed calculation instructions
3
[ "Renal", "insufficiency", "(", "estimated", "glomerular", "filtration", "rate", "<", "30", "mL/min/1.73m2", "e.g", ".", "calculated", "based", "on", "Schwartz", "formula", ",", "for", "detailed", "calculation", "instructions" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01774019
1:29:chronic_disease
Biliary obstructive symptoms or signs
3
[ "Biliary", "obstructive", "symptoms", "or", "signs" ]
[ 2, 2, 2, 0, 0 ]
NCT00720785
1:38:chronic_disease
Psychiatric illness/social situations that would limit compliance with study requirements and ability to comprehend the investigational nature of the study and provide informed consent
3
[ "Psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements", "and", "ability", "to", "comprehend", "the", "investigational", "nature", "of", "the", "study", "and", "provide", "informed", "consent" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01666080
70:77:chronic_disease
Occasionally donor derived engraftment may be present, but sustained aplasia or failed recovery of sufficient hematopoiesis requires administration of a second graft
3
[ "Occasionally", "donor", "derived", "engraftment", "may", "be", "present", ",", "but", "sustained", "aplasia", "or", "failed", "recovery", "of", "sufficient", "hematopoiesis", "requires", "administration", "of", "a", "second", "graft" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00919503
15:41:chronic_disease,26:41:chronic_disease,46:60:chronic_disease,109:150:chronic_disease,154:188:chronic_disease
Patients with idiopathic aplastic anemia and Fanconi anemia; (patients with aplastic anemia associated with paroxysmal nocturnal hemoglobinuria [PNH] or inherited marrow failure syndromes, except Fanconi anemia, will be allowed)
3
[ "Patients", "with", "idiopathic", "aplastic", "anemia", "and", "Fanconi", "anemia", ";", "(", "patients", "with", "aplastic", "anemia", "associated", "with", "paroxysmal", "nocturnal", "hemoglobinuria", "[", "PNH", "]", "or", "inherited", "marrow", "failure", "syndromes", ",", "except", "Fanconi", "anemia", ",", "will", "be", "allowed", ")" ]
[ 0, 0, 2, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02208362
45:57:cancer
Research participants with any other active malignancies
3
[ "Research", "participants", "with", "any", "other", "active", "malignancies" ]
[ 0, 0, 0, 0, 0, 0, 3 ]
NCT01760655
19:29:cancer,33:42:chronic_disease,122:126:treatment
Any hematological malignancy or dyscrasia not cited above which is thought to be high-risk with increased chance of post HSCT relapse
3
[ "Any", "hematological", "malignancy", "or", "dyscrasia", "not", "cited", "above", "which", "is", "thought", "to", "be", "high-risk", "with", "increased", "chance", "of", "post", "HSCT", "relapse" ]
[ 0, 0, 3, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02963831
15:44:cancer,48:71:chronic_disease,144:159:treatment,163:178:treatment,
Subjects with asymptomatic brain metastases or spinal cord compression who have been treated, are considered stable, and who have not received corticosteroids or anticonvulsants for at least 28 days prior to screening may be included
3
[ "Subjects", "with", "asymptomatic", "brain", "metastases", "or", "spinal", "cord", "compression", "who", "have", "been", "treated", ",", "are", "considered", "stable", ",", "and", "who", "have", "not", "received", "corticosteroids", "or", "anticonvulsants", "for", "at", "least", "28", "days", "prior", "to", "screening", "may", "be", "included" ]
[ 0, 0, 3, 3, 3, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02392572
,,,,,,,,,,,313:323:treatment
Women of child-bearing potential (i.e., women who are pre-menopausal or not surgically sterile) must use acceptable contraceptive methods (abstinence, intrauterine device [IUD], oral contraceptive or double barrier device, such as a condom, diaphragm, or cervical/vault cap), for 16 weeks after the last dose of study drug
3
[ "Women", "of", "child-bearing", "potential", "(", "i.e.", ",", "women", "who", "are", "pre-menopausal", "or", "not", "surgically", "sterile", ")", "must", "use", "acceptable", "contraceptive", "methods", "(", "abstinence", ",", "intrauterine", "device", "[", "IUD", "]", ",", "oral", "contraceptive", "or", "double", "barrier", "device", ",", "such", "as", "a", "condom", ",", "diaphragm", ",", "or", "cervical/vault", "cap", ")", ",", "for", "16", "weeks", "after", "the", "last", "dose", "of", "study", "drug" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02702492
1:20:treatment,
Palliative steroids for disease related symptoms < 7 days prior to C1D1
3
[ "Palliative", "steroids", "for", "disease", "related", "symptoms", "<", "7", "days", "prior", "to", "C1D1" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02424968
1:35:chronic_disease
Human immunodeficiency virus (HIV) positive
3
[ "Human", "immunodeficiency", "virus", "(", "HIV", ")", "positive" ]
[ 2, 2, 2, 2, 0, 0, 0 ]
NCT02101944
,,140:158:treatment,
Patients must be able to avoid direct contact with pregnant or nursing women, infants and immunocompromised individuals during the days of reolysin treatment and for two days after
3
[ "Patients", "must", "be", "able", "to", "avoid", "direct", "contact", "with", "pregnant", "or", "nursing", "women", ",", "infants", "and", "immunocompromised", "individuals", "during", "the", "days", "of", "reolysin", "treatment", "and", "for", "two", "days", "after" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02133573
49:61:allergy_name,114:140:allergy_name,142:170:allergy_name,172:179:allergy_name,183:206:allergy_name,208:224:allergy_name,226:250:allergy_name,252:271:allergy_name,273:282:allergy_name
Known sensitivity or listed contraindication to progesterone (known allergy or hypersensitivity to progesterone, severe hepatic dysfunction, undiagnosed vaginal bleeding, mammary or genital tract carcinoma, thrombophlebitis, thromboembolic disorders, cerebral hemorrhage, porphyria)
3
[ "Known", "sensitivity", "or", "listed", "contraindication", "to", "progesterone", "(", "known", "allergy", "or", "hypersensitivity", "to", "progesterone", ",", "severe", "hepatic", "dysfunction", ",", "undiagnosed", "vaginal", "bleeding", ",", "mammary", "or", "genital", "tract", "carcinoma", ",", "thrombophlebitis", ",", "thromboembolic", "disorders", ",", "cerebral", "hemorrhage", ",", "porphyria", ")" ]
[ 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 4, 4, 4, 0, 4, 0, 4, 4, 4, 0, 4, 0, 4, 4, 0, 4, 4, 0, 4, 0 ]
NCT02268253
,,,171:186:treatment
agrees to use acceptable contraceptive methods for the duration of time in the study, and to continue to use acceptable contraceptive methods for 2 months after the last SL-401 infusion
3
[ "agrees", "to", "use", "acceptable", "contraceptive", "methods", "for", "the", "duration", "of", "time", "in", "the", "study", ",", "and", "to", "continue", "to", "use", "acceptable", "contraceptive", "methods", "for", "2", "months", "after", "the", "last", "SL-401", "infusion" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03176173
47:60:treatment,85:102:treatment,121:145:treatment,142:144:treatment,149:183:treatment,,304:320:cancer,322:360:treatment,356:359:treatment,
Has had restaging imaging after initiation of immunotherapy, at least 4 weeks after pre-immunotherapy baseline imaging; computed tomography (CT) or positron emission tomography (PET)/CT of at least chest/upper abdomen must be performed within 4 weeks prior to registration; for patients with history of brain metastases, brain magnetic resonance imaging (MRI) or CT is required within 4 weeks of registration; for other patients brain MRI or CT is required within 12 weeks of registration
3
[ "Has", "had", "restaging", "imaging", "after", "initiation", "of", "immunotherapy", ",", "at", "least", "4", "weeks", "after", "pre-immunotherapy", "baseline", "imaging", ";", "computed", "tomography", "(", "CT", ")", "or", "positron", "emission", "tomography", "(", "PET", ")", "/CT", "of", "at", "least", "chest/upper", "abdomen", "must", "be", "performed", "within", "4", "weeks", "prior", "to", "registration", ";", "for", "patients", "with", "history", "of", "brain", "metastases", ",", "brain", "magnetic", "resonance", "imaging", "(", "MRI", ")", "or", "CT", "is", "required", "within", "4", "weeks", "of", "registration", ";", "for", "other", "patients", "brain", "MRI", "or", "CT", "is", "required", "within", "12", "weeks", "of", "registration" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02403193
12:34:treatment,
history of bilateral oophorectomy) or must have a negative serum pregnancy test upon study entry
3
[ "history", "of", "bilateral", "oophorectomy", ")", "or", "must", "have", "a", "negative", "serum", "pregnancy", "test", "upon", "study", "entry" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02352467
1:6:chronic_disease
Ulcer of pressure/shear etiology (Stage II, III, and IV, see Appendix 9 for stage definitions)
3
[ "Ulcer", "of", "pressure/shear", "etiology", "(", "Stage", "II", ",", "III", ",", "and", "IV", ",", "see", "Appendix", "9", "for", "stage", "definitions", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02725567
1:34:chronic_disease
Chronic kidney disease of Stage 3 or above
3
[ "Chronic", "kidney", "disease", "of", "Stage", "3", "or", "above" ]
[ 2, 2, 2, 2, 2, 2, 0, 0 ]
NCT02058095
20:44:chronic_disease,,
Prior diagnosis of intrinsic renal diseases including renal artery stenosis of > 50%
3
[ "Prior", "diagnosis", "of", "intrinsic", "renal", "diseases", "including", "renal", "artery", "stenosis", "of", ">", "50", "%" ]
[ 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01872975
1:106:treatment,30:34:cancer,36:52:cancer
Patient must have clinically T1-3, N1 breast cancer at the time of diagnosis (before neoadjuvant therapy)
3
[ "Patient", "must", "have", "clinically", "T1-3", ",", "N1", "breast", "cancer", "at", "the", "time", "of", "diagnosis", "(", "before", "neoadjuvant", "therapy", ")" ]
[ 1, 1, 1, 1, 3, 1, 3, 3, 3, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0 ]
NCT01434316
,,53:60:treatment,65:74:treatment,79:104:treatment,263:272:treatment
Pregnant women are excluded from this study because ABT-888 and SCH727965 are anti-proliferative agents with the potential for teratogenic or abortifacient effects; because there is an unknown but potential risk of adverse events in nursing infants secondary to treatment of the mother with ABT-888 and SCH727965, breastfeeding should be discontinued if the mother is treated with ABT-888 and SCH727965; these potential risks may also apply to other agents used in this study
3
[ "Pregnant", "women", "are", "excluded", "from", "this", "study", "because", "ABT-888", "and", "SCH727965", "are", "anti-proliferative", "agents", "with", "the", "potential", "for", "teratogenic", "or", "abortifacient", "effects", ";", "because", "there", "is", "an", "unknown", "but", "potential", "risk", "of", "adverse", "events", "in", "nursing", "infants", "secondary", "to", "treatment", "of", "the", "mother", "with", "ABT-888", "and", "SCH727965", ",", "breastfeeding", "should", "be", "discontinued", "if", "the", "mother", "is", "treated", "with", "ABT-888", "and", "SCH727965", ";", "these", "potential", "risks", "may", "also", "apply", "to", "other", "agents", "used", "in", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02972840
26:29:cancer
Pathologically confirmed MCL, with documentation of a chromosome translocation t(11;14)(q13;q32) and/or overexpression of cyclin D1 in association with other relevant markers (eg, CD5, CD19, CD20, PAX5)
3
[ "Pathologically", "confirmed", "MCL", ",", "with", "documentation", "of", "a", "chromosome", "translocation", "t", "(", "11", ";", "14", ")", "(", "q13", ";", "q32", ")", "and/or", "overexpression", "of", "cyclin", "D1", "in", "association", "with", "other", "relevant", "markers", "(", "eg", ",", "CD5", ",", "CD19", ",", "CD20", ",", "PAX5", ")" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01773707
31:39:chronic_disease
Abnormal Glucose Tolerance or Diabetes
3
[ "Abnormal", "Glucose", "Tolerance", "or", "Diabetes" ]
[ 0, 0, 0, 0, 2 ]
NCT02203695
42:54:cancer,
Patients must be disease-free from prior malignancies for greater than 3 years
3
[ "Patients", "must", "be", "disease-free", "from", "prior", "malignancies", "for", "greater", "than", "3", "years" ]
[ 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT02570672
33:51:chronic_disease,84:103:chronic_disease,105:133:chronic_disease,135:155:chronic_disease,157:185:chronic_disease,187:203:chronic_disease
Chronic inflammatory condition, autoimmune disease, or infectious processes (e.g., active tuberculosis, Human Immunodeficiency Virus, rheumatoid arthritis, systemic lupus erythematosus, hepatitis B or C)
3
[ "Chronic", "inflammatory", "condition", ",", "autoimmune", "disease", ",", "or", "infectious", "processes", "(", "e.g.", ",", "active", "tuberculosis", ",", "Human", "Immunodeficiency", "Virus", ",", "rheumatoid", "arthritis", ",", "systemic", "lupus", "erythematosus", ",", "hepatitis", "B", "or", "C", ")" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2, 2, 0 ]
NCT02451488
28:54:chronic_disease
Patients with a history of inflammatory bowel disease
3
[ "Patients", "with", "a", "history", "of", "inflammatory", "bowel", "disease" ]
[ 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT03062462
,,,104:120:treatment,
PAgR is more than 46% and the percentage of inhibition of ADP-induced platelet aggregation measured by thrombelastogram is not more than 30%
3
[ "PAgR", "is", "more", "than", "46", "%", "and", "the", "percentage", "of", "inhibition", "of", "ADP-induced", "platelet", "aggregation", "measured", "by", "thrombelastogram", "is", "not", "more", "than", "30", "%" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02601833
55:58:allergy_name
sensitivity to dental materials being used, including SDF
3
[ "sensitivity", "to", "dental", "materials", "being", "used", ",", "including", "SDF" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 4 ]
NCT02498535
8:19:treatment,21:25:treatment,27:43:treatment,52:59:treatment,65:91:chronic_disease,
Use of antibiotics [oral, intravenous (iv), and/or inhaled] for acute respiratory symptoms within 2 weeks prior to baseline
3
[ "Use", "of", "antibiotics", "[", "oral", ",", "intravenous", "(", "iv", ")", ",", "and/or", "inhaled", "]", "for", "acute", "respiratory", "symptoms", "within", "2", "weeks", "prior", "to", "baseline" ]
[ 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02562755
1:52:chronic_disease
Adequate hematological, hepatic, and renal function
3
[ "Adequate", "hematological", ",", "hepatic", ",", "and", "renal", "function" ]
[ 2, 2, 2, 2, 2, 2, 0, 0 ]
NCT01306019
1:21:cancer,,
Childhood malignancy (occurring before 18 years of age) in the patient or a first degree relative
3
[ "Childhood", "malignancy", "(", "occurring", "before", "18", "years", "of", "age", ")", "in", "the", "patient", "or", "a", "first", "degree", "relative" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01174121
12:36:chronic_disease
Concurrent opportunistic infections
3
[ "Concurrent", "opportunistic", "infections" ]
[ 0, 2, 2 ]
NCT03089281
26:59:treatment
have previously received cardiac resynchronization therapy with pacing in the left ventricle
3
[ "have", "previously", "received", "cardiac", "resynchronization", "therapy", "with", "pacing", "in", "the", "left", "ventricle" ]
[ 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01734512
53:56:treatment
Progressive or recurrent disease should be based on MRI according to the definition below
3
[ "Progressive", "or", "recurrent", "disease", "should", "be", "based", "on", "MRI", "according", "to", "the", "definition", "below" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02227199
22:63:treatment,
Patients must have a CT of chest, abdomen, and pelvis with PET within 28 days of enrollment
3
[ "Patients", "must", "have", "a", "CT", "of", "chest", ",", "abdomen", ",", "and", "pelvis", "with", "PET", "within", "28", "days", "of", "enrollment" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02413047
5:44:chronic_disease,46:55:chronic_disease,57:64:chronic_disease,66:71:chronic_disease,73:92:chronic_disease,103:119:chronic_disease
Any unstable or uncontrolled cardiovascular, pulmonary, hepatic, renal, endocrine/metabolic, or other medical disorder that, in the opinion of the investigator, would confound the study results or compromise patient safety
3
[ "Any", "unstable", "or", "uncontrolled", "cardiovascular", ",", "pulmonary", ",", "hepatic", ",", "renal", ",", "endocrine/metabolic", ",", "or", "other", "medical", "disorder", "that", ",", "in", "the", "opinion", "of", "the", "investigator", ",", "would", "confound", "the", "study", "results", "or", "compromise", "patient", "safety" ]
[ 0, 2, 2, 2, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02283333
21:45:chronic_disease
with a diagnosis of Prolonged Grief Disorder
3
[ "with", "a", "diagnosis", "of", "Prolonged", "Grief", "Disorder" ]
[ 0, 0, 0, 0, 2, 2, 2 ]
NCT02102854
40:67:treatment
Rejection episode requiring the use of therapeutic plasma exchange immediately subsequent to rATG administration
3
[ "Rejection", "episode", "requiring", "the", "use", "of", "therapeutic", "plasma", "exchange", "immediately", "subsequent", "to", "rATG", "administration" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02578901
26:48:cancer,52:59:chronic_disease
Confirmed diagnosis of a hematologic malignancy or aplasia
3
[ "Confirmed", "diagnosis", "of", "a", "hematologic", "malignancy", "or", "aplasia" ]
[ 0, 0, 0, 0, 3, 3, 0, 2 ]
NCT01508390
17:43:chronic_disease
No diagnosis of inflammatory bowel disease
3
[ "No", "diagnosis", "of", "inflammatory", "bowel", "disease" ]
[ 0, 0, 0, 2, 2, 2 ]
NCT02512926
71:89:treatment,91:104:treatment,106:118:treatment,123:130:treatment
Patient must have fully recovered from the acute toxic effects of all prior chemotherapy, immunotherapy, radiotherapy, or surgery prior to study entry
3
[ "Patient", "must", "have", "fully", "recovered", "from", "the", "acute", "toxic", "effects", "of", "all", "prior", "chemotherapy", ",", "immunotherapy", ",", "radiotherapy", ",", "or", "surgery", "prior", "to", "study", "entry" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0 ]
NCT02236000
1:27:chronic_disease
inflammatory bowel disease
3
[ "inflammatory", "bowel", "disease" ]
[ 2, 2, 2 ]
NCT02301611
1:26:chronic_disease,47:50:chronic_disease,52:55:chronic_disease,57:60:chronic_disease
Immune deficiency disease or known history of HIV, HBV, HCV
3
[ "Immune", "deficiency", "disease", "or", "known", "history", "of", "HIV", ",", "HBV", ",", "HCV" ]
[ 2, 2, 2, 0, 0, 0, 0, 2, 0, 2, 0, 2 ]
NCT01824836
12:34:treatment
history of bilateral oophorectomy
3
[ "history", "of", "bilateral", "oophorectomy" ]
[ 0, 0, 1, 1 ]
NCT02369458
104:115:allergy_name
A history of allergic reactions attributed to compounds of similar chemical or biologic composition to mitomycin C or other agents used in the study
3
[ "A", "history", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "mitomycin", "C", "or", "other", "agents", "used", "in", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0 ]
NCT01794793
,,,,183:192:treatment,,233:249:treatment,,286:301:treatment
Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, unless they are using highly effective methods of contraception during the study treatment and for 30 days after the final dose of pasireotide s.c. and 84 days after the final dose of pasireotide LAR
3
[ "Women", "of", "child-bearing", "potential", ",", "defined", "as", "all", "women", "physiologically", "capable", "of", "becoming", "pregnant", ",", "unless", "they", "are", "using", "highly", "effective", "methods", "of", "contraception", "during", "the", "study", "treatment", "and", "for", "30", "days", "after", "the", "final", "dose", "of", "pasireotide", "s.c.", "and", "84", "days", "after", "the", "final", "dose", "of", "pasireotide", "LAR" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02425904
,,106:109:chronic_disease
AST (SGOT)/ALT (SGPT) < 2.5 X institutional upper limit of normal unless it is related to involvement by LCH
3
[ "AST", "(", "SGOT", ")", "/ALT", "(", "SGPT", ")", "<", "2.5", "X", "institutional", "upper", "limit", "of", "normal", "unless", "it", "is", "related", "to", "involvement", "by", "LCH" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02515110
36:68:cancer
patients with margins positive for lobular carcinoma in situ (LCIS) are eligible without additional resection
3
[ "patients", "with", "margins", "positive", "for", "lobular", "carcinoma", "in", "situ", "(", "LCIS", ")", "are", "eligible", "without", "additional", "resection" ]
[ 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT02551679
20:37:treatment,
Subject received a blood transfusion during the previous 4 weeks (to exclude the potential of non-autologous ACPs in the harvested blood)
3
[ "Subject", "received", "a", "blood", "transfusion", "during", "the", "previous", "4", "weeks", "(", "to", "exclude", "the", "potential", "of", "non-autologous", "ACPs", "in", "the", "harvested", "blood", ")" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01988246
1:10:treatment,16:27:treatment,31:50:treatment,,93:100:treatment
Treatment with intraocular or periocular steroids in the study eye within 3 months prior to surgery
3
[ "Treatment", "with", "intraocular", "or", "periocular", "steroids", "in", "the", "study", "eye", "within", "3", "months", "prior", "to", "surgery" ]
[ 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02448173
,29:59:cancer
Patients with more than one malignant primary colon cancer will be excluded
3
[ "Patients", "with", "more", "than", "one", "malignant", "primary", "colon", "cancer", "will", "be", "excluded" ]
[ 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0 ]
NCT02073097
,5:21:cancer
≥ 2 extranodal sites (1 point)
3
[ "≥", "2", "extranodal", "sites", "(", "1", "point", ")" ]
[ 0, 0, 3, 3, 0, 0, 0, 0 ]
NCT01367444
5:45:treatment,
Any periocular injections of corticosteroids to the treated eye within 4 months prior to screening
3
[ "Any", "periocular", "injections", "of", "corticosteroids", "to", "the", "treated", "eye", "within", "4", "months", "prior", "to", "screening" ]
[ 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02481245
12:38:chronic_disease
History of Type 1 or Type II Diabetes
3
[ "History", "of", "Type", "1", "or", "Type", "II", "Diabetes" ]
[ 0, 0, 2, 2, 2, 2, 2, 2 ]
NCT02312570
10:19:treatment,21:30:treatment,34:43:treatment,
Received allograft, autograft or xenograft within 30 days of enrollment
3
[ "Received", "allograft", ",", "autograft", "or", "xenograft", "within", "30", "days", "of", "enrollment" ]
[ 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0 ]
NCT02982772
29:45:allergy_name
History of allergies to the nicotine patches
3
[ "History", "of", "allergies", "to", "the", "nicotine", "patches" ]
[ 0, 0, 0, 0, 0, 4, 4 ]
NCT03093272
1:17:chronic_disease,25:59:chronic_disease,63:78:chronic_disease
Active infection (e.g., human immunodeficiency virus [HIV] or viral hepatitis)
3
[ "Active", "infection", "(", "e.g.", ",", "human", "immunodeficiency", "virus", "[", "HIV", "]", "or", "viral", "hepatitis", ")" ]
[ 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 0 ]
NCT02373644
1:17:treatment,21:43:treatment,
Physical therapy or chiropractic treatment for low back pain in the 3 months before initial examination
3
[ "Physical", "therapy", "or", "chiropractic", "treatment", "for", "low", "back", "pain", "in", "the", "3", "months", "before", "initial", "examination" ]
[ 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02252432
25:33:treatment,37:46:treatment,47:63:treatment
Those already receiving ketamine or methadone prior to surgery
3
[ "Those", "already", "receiving", "ketamine", "or", "methadone", "prior", "to", "surgery" ]
[ 0, 0, 0, 1, 0, 1, 1, 1, 1 ]
NCT01880567
17:20:cancer,,
Newly diagnosed MCL: Age > 65 years at the time of signing the informed consent
3
[ "Newly", "diagnosed", "MCL", ":", "Age", ">", "65", "years", "at", "the", "time", "of", "signing", "the", "informed", "consent" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03145181
31:46:treatment,,113:123:treatment,,203:226:treatment
Received a cumulative dose of corticosteroids equivalent to greater than or equal to (>=) 140 milligram (mg) of prednisone within the 14-day period before the first dose of study drug (does not include pretreatment medication)
3
[ "Received", "a", "cumulative", "dose", "of", "corticosteroids", "equivalent", "to", "greater", "than", "or", "equal", "to", "(", ">", "=", ")", "140", "milligram", "(", "mg", ")", "of", "prednisone", "within", "the", "14-day", "period", "before", "the", "first", "dose", "of", "study", "drug", "(", "does", "not", "include", "pretreatment", "medication", ")" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0 ]